EVA1A and breast cancer: Additionally, Zhen et al. discovered that flubendazole, which was found to have anti-cancer effects via targeting eva-1 homolog A (EVA1A)-modulated autophagy and apoptosis before 195, could induce mitochondrial dysfunction and Drp1-mediated mitophagy by targeting EVA1A in breast cancer 196.